Global Lupus Nephritis Treatment Market Size, Share, Trends, Industry Growth by Drug Class (Corticosteroids, Immunosuppressive, Belimumab), by Route of Administration (Oral, Parenteral), by Distribution Channel, by Region, and Forecast to 2030

Price: 3795/- USD | Published Date: March 16, 2023 |

The global lupus nephritis treatment market size was valued at around USD 2 billion in 2022 and anticipated to grow at a significant growth rate (CAGR) of over 10% during the forecast period from 2023 to 2030. By region, North America is estimated to hold the largest market share in the benchmark year owing to the rising prevalence of lupus disease in the region.

The rising cases of lupus disease, growing awareness regarding the disease, and the emergence of novel treatments are estimated to drive the lupus nephritis treatment industry at a significant growth rate. According to the Lupus Foundation of America, about 5 million people worldwide are affected by the disease. It is further estimated that 1.5 million Americans are affected by lupus disease and 16,000 new cases are reported each year in America. Furthermore, the development of new drugs to treat the disease such as voclosporin and belimumab is further anticipated to propel the market growth significantly. Moreover, the rising demand for effective treatments, the introduction of new drugs, technological advancement in healthcare facilities, rising initiatives by public and private organizations, and the growing investment in research & development are further anticipated to fuel the market growth.

Global Lupus Nephritis Treatment Attributes:

Benchmark Year 2022
Market Size ~ USD 2 Billion in 2022
Market Growth (CAGR) > 10 %
Largest Market Share North America
Analysis Period 2020-2030

Market Insights:

The global lupus nephritis treatment market is bifurcated into drug class, route of administration, distribution channel, and geography. On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy dominated the global market in 2022 and estimated to maintain its dominance over the forecast period. Hospital pharmacies usually carry specific medications that are needed to treat complex conditions such as lupus nephritis. Furthermore, the Presence of clinical pharmacists, who have specialized knowledge and training in treating complex medical conditions, is further anticipated to propel the segment growth over the forecast period.

The global lupus nephritis treatment market report explores the critical analysis of the industry using key parameters. The report covers investment strategies, the need for investment in the industry, and several benefits for investors. Significantly, this report sets out major changes in the global technical regulations for the market, as well as how economic and non-economic constraints are helping the market to grow. Furthermore, the report analyzes the historic and forecasted market size at the global, regional, and country-level. The report also provides a comprehensive analysis of key investment proposals, competitor positions, porter’s five force analysis, SWOT analysis, pestel analysis, value chain analysis, etc.

Lupus Nephritis Treatment Market Size

To know more about the research study, request sample papers

The lupus nephritis treatment comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2023 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Historical & Forecast Period

  • 2020-21 – Historical Year
  • 2022 – Base Year
  • 2023-2030 – Forecast Period

Global Lupus Nephritis Treatment Market Segmentation:

Lupus Nephritis Treatment Market by Drug Class:

  • Corticosteroids
  • Immunosuppressive
    • Azathioprine
    • Cyclophosphamide
    • Mycophenolate
  • Belimumab

Lupus Nephritis Treatment Market by Route of Administration:

  • Oral
  • Parenteral

Lupus Nephritis Treatment Market by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Lupus Nephritis Treatment Market by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Lupus Nephritis Treatment Market: Geographic Coverage

Geographically, the lupus nephritis treatment market report comprises dedicated sections centering on the regional market revenue and trends. The lupus nephritis treatment market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The lupus nephritis treatment market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Lupus nephritis treatment market estimates have also been provided for the historical years 2020 & 2021 along with forecasts for the period from 2023 – 2030.

Lupus Nephritis Treatment Market: Competitive Assessment

Some of the major market players operating in the global lupus nephritis treatment market are Roche, Bristol-Myers Squibb, Eli Lilly, and Company, GlaxoSmithKline, and AstraZeneca. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Roche
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • GlaxoSmithKline
  • AstraZeneca
  • Aurinia Pharmaceuticals Inc.
  • Johnson & Johnson Private Limited
  • Bayer AG
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Abbott

Key Questions Answered by Lupus Nephritis Treatment Market Report

  • Global lupus nephritis treatment market forecasts from 2023-2030
  • Regional market forecasts from 2023-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
  • Country-level forecasts from 2023-2030 covering 15 major countries from the regions as mentioned above
  • Lupus nephritis treatment submarket forecasts from 2023-2030 covering the market by drug class, route of administration, distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis about the market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level lupus nephritis treatment markets from 2023-2030
  • Competitive Landscape and market positioning of the top 10 players operating in the market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Lupus Nephritis Treatment Market Portraiture
2.2. Global Lupus Nephritis Treatment Market, by Drug Class, 2022 (USD Mn)
2.3. Global Lupus Nephritis Treatment Market, by Route of Administration, 2022 (USD Mn)
2.4. Global Lupus Nephritis Treatment Market, by Distribution Channel, 2022 (USD Mn)
2.5. Global Lupus Nephritis Treatment Market, by Geography, 2022 (USD Mn)

 

3. Global Lupus Nephritis Treatment Market Analysis


3.1. Lupus Nephritis Treatment Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. PESTLE Analysis
3.8. COVID-19 Impact Analysis

 

4. Global Lupus Nephritis Treatment Market By Drug Class, 2020 – 2030 (USD Mn)


4.1. Overview
4.2. Corticosteroids
4.3. Immunosuppressive
4.3.1. Azathioprine
4.3.2. Cyclophosphamide
4.3.3. Mycophenolate
4.4. Belimumab

 

5. Global Lupus Nephritis Treatment Market By Route of Administration, 2020 – 2030 (USD Mn)


5.1. Overview
5.2. Oral
5.3. Parenteral

 

6. Global Lupus Nephritis Treatment Market By Distribution Channel, 2020 – 2030 (USD Mn)


6.1. Overview
6.2. Hospital Pharmacy
6.3. Retail Pharmacy
6.4. Online Pharmacy

 

7. North America Lupus Nephritis Treatment Market Analysis and Forecast, 2020 – 2030 (USD Mn)


7.1. Overview
7.2. North America Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
7.3. North America Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
7.4. North America Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
7.5. North America Lupus Nephritis Treatment Market by Country, (2020-2030 USD Mn)
7.5.1. U.S.
7.5.1.1. U.S. Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
7.5.1.2. U.S. Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
7.5.1.3. U.S. Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
7.5.2. Canada
7.5.2.1. Canada Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
7.5.2.2. Canada Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
7.5.2.3. Canada Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)

 

8. Europe Lupus Nephritis Treatment Market Analysis and Forecast, 2020 - 2030 (USD Mn)


8.1. Overview
8.2. Europe Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
8.3. Europe Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
8.4. Europe Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
8.5. Europe Lupus Nephritis Treatment Market by Country, (2020-2030 USD Mn)
8.5.1. Germany
8.5.1.1. Germany Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
8.5.1.2. Germany Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
8.5.1.3. Germany Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
8.5.2. U.K.
8.5.2.1. U.K. Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
8.5.2.2. U.K. Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
8.5.2.3. U.K. Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
8.5.3. France
8.5.3.1. France Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
8.5.3.2. France Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
8.5.3.3. France Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
8.5.4. Spain
8.5.4.1. Spain Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
8.5.4.2. Spain Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
8.5.4.3. Spain Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
8.5.5. Italy
8.5.5.1. Italy Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
8.5.5.2. Italy Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
8.5.5.3. Italy Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
8.5.6. Rest of Europe
8.5.6.1. Rest of Europe Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
8.5.6.2. Rest of Europe Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
8.5.6.3. Rest of Europe Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)

 

9. Asia Pacific Lupus Nephritis Treatment Market Analysis and Forecast, 2020 - 2030 (USD Mn)


9.1. Overview
9.2. Asia Pacific Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
9.3. Asia Pacific Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
9.4. Asia Pacific Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
9.5. Asia Pacific Lupus Nephritis Treatment Market by Country, (2020-2030 USD Mn)
9.5.1. China
9.5.1.1. China Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
9.5.1.2. China Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
9.5.1.3. China Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
9.5.2. Japan
9.5.2.1. Japan Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
9.5.2.2. Japan Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
9.5.2.3. Japan Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
9.5.3. India
9.5.3.1. India Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
9.5.3.2. India Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
9.5.3.3. India Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
9.5.4. Rest of Asia Pacific
9.5.4.1. Rest of Asia Pacific Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
9.5.4.2. Rest of Asia Pacific Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
9.5.4.3. Rest of Asia Pacific Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)

 

10. Latin America (LATAM) Lupus Nephritis Treatment Market Analysis and Forecast, 2020 - 2030 (USD Mn)


10.1. Overview
10.2. Latin America Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
10.3. Latin America Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
10.4. Latin America Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
10.5. Latin America Lupus Nephritis Treatment Market by Country, (2020-2030 USD Mn)
10.5.1. Brazil
10.5.1.1. Brazil Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
10.5.1.2. Brazil Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
10.5.1.3. Brazil Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
10.5.2. Mexico
10.5.2.1. Mexico Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
10.5.2.2. Mexico Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
10.5.2.3. Mexico Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
10.5.3. Rest of Latin America
10.5.3.1. Rest of Latin America Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
10.5.3.2. Rest of Latin America Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
10.5.3.3. Rest of Latin America Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)

 

11. Middle East and Africa Lupus Nephritis Treatment Market Analysis and Forecast, 2020 - 2030 (USD Mn)


11.1. Overview
11.2. MEA Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
11.3. MEA Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
11.4. MEA Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
11.5. Middle East and Africa Lupus Nephritis Treatment Market, by Country, (2020-2030 USD Mn)
11.5.1. GCC
11.5.1.1. GCC Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
11.5.1.2. GCC Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
11.5.1.3. GCC Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
11.5.2. South Africa
11.5.2.1. South Africa Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
11.5.2.2. South Africa Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
11.5.2.3. South Africa Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)
11.5.3. Rest of MEA
11.5.3.1. Rest of MEA Lupus Nephritis Treatment Market by Drug Class, (2020-2030 USD Mn)
11.5.3.2. Rest of MEA Lupus Nephritis Treatment Market by Route of Administration, (2020-2030 USD Mn)
11.5.3.3. Rest of MEA Lupus Nephritis Treatment Market by Distribution Channel, (2020-2030 USD Mn)

 

12. Company Profiles


12.1. Roche
12.1.1. Business Description
12.1.2. Financial Health and Budget Allocation
12.1.3. Product Positions/Portfolio
12.1.4. Recent Development
12.1.5. SWOT Analysis
12.2. Bristol-Myers Squibb
12.2.1. Business Description
12.2.2. Financial Health and Budget Allocation
12.2.3. Product Positions/Portfolio
12.2.4. Recent Development
12.2.5. SWOT Analysis
12.3. Eli Lilly and Company
12.3.1. Business Description
12.3.2. Financial Health and Budget Allocation
12.3.3. Product Positions/Portfolio
12.3.4. Recent Development
12.3.5. SWOT Analysis
12.4. GlaxoSmithKline
12.4.1. Business Description
12.4.2. Financial Health and Budget Allocation
12.4.3. Product Positions/Portfolio
12.4.4. Recent Development
12.4.5. SWOT Analysis
12.5. AstraZeneca
12.5.1. Business Description
12.5.2. Financial Health and Budget Allocation
12.5.3. Product Positions/Portfolio
12.5.4. Recent Development
12.5.5. SWOT Analysis
12.6. Aurinia Pharmaceuticals Inc.
12.6.1. Business Description
12.6.2. Financial Health and Budget Allocation
12.6.3. Product Positions/Portfolio
12.6.4. Recent Development
12.6.5. SWOT Analysis
12.7. Johnson & Johnson Private Limited
12.7.1. Business Description
12.7.2. Financial Health and Budget Allocation
12.7.3. Product Positions/Portfolio
12.7.4. Recent Development
12.7.5. SWOT Analysis
12.8. Bayer AG
12.8.1. Business Description
12.8.2. Financial Health and Budget Allocation
12.8.3. Product Positions/Portfolio
12.8.4. Recent Development
12.8.5. SWOT Analysis
12.9. Sanofi
12.9.1. Business Description
12.9.2. Financial Health and Budget Allocation
12.9.3. Product Positions/Portfolio
12.9.4. Recent Development
12.9.5. SWOT Analysis
12.10. Sun Pharmaceutical Industries Ltd.
12.10.1. Business Description
12.10.2. Financial Health and Budget Allocation
12.10.3. Product Positions/Portfolio
12.10.4. Recent Development
12.10.5. SWOT Analysis
12.11. Abbott
12.11.1. Business Description
12.11.2. Financial Health and Budget Allocation
12.11.3. Product Positions/Portfolio
12.11.4. Recent Development
12.11.5. SWOT Analysis
Fill the given form to inquiry before buying for Global Lupus Nephritis Treatment Market Size, Share, Trends, Industry Growth by Drug Class (Corticosteroids, Immunosuppressive, Belimumab), by Route of Administration (Oral, Parenteral), by Distribution Channel, by Region, and Forecast to 2030 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying
Schedule a Call


Select License Type
$ 3795/- Single User License
$ 5995/- Multi User License
$ 7995/- Corporate License

Paypal Certified Payment
For Any Assitance

Email: sales@researchcorridor.com
Schedule a Call

Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price

Impacts of COVID-19
COVID-19 Impact on the Global Lupus Nephritis Treatment Market Size, Share, Trends, Industry Growth by Drug Class (Corticosteroids, Immunosuppressive, Belimumab), by Route of Administration (Oral, Parenteral), by Distribution Channel, by Region, and Forecast to 2030 Market

Latest Market Insights
Get in Touch

Please fill the given below details, our team will contact you soon:


Our Clients